Literature DB >> 16336480

Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool.

Lynn R Webster1, Rebecca M Webster.   

Abstract

OBJECTIVE: To provide clinicians with a brief screening tool to predict accurately which individuals may develop aberrant behaviors when prescribed opioids for chronic pain.
DESIGN: One hundred and eighty-five consecutive new patients treated in one pain clinic took the self-administered Opioid Risk Tool (ORT). The ORT measured the following risk factors associated in scientific literature with substance abuse: personal and family history of substance abuse; age; history of preadolescent sexual abuse; and certain psychological diseases. Patients received scores of 0-3 (low risk), 4-7 (moderate risk), or >or= 8 (high risk), indicating the probability of their displaying opioid-related aberrant behaviors. All patients were monitored for aberrant behaviors for 12 months after their initial visits.
RESULTS: For those patients with a risk category of low, 17 out of 18 (94.4%) did not display an aberrant behavior. For those patients with a risk category of high, 40 out of 44 (90.9%) did display an aberrant behavior. The authors used the c statistic to validate the ORT, because it simultaneously assesses sensitivity and specificity. The ORT displayed excellent discrimination for both the male (c = 0.82) and the female (c = 0.85) prognostic models.
CONCLUSION: In a preliminary study, among patients prescribed opioids for chronic pain, the ORT exhibited a high degree of sensitivity and specificity for determining which individuals are at risk for opioid-related, aberrant behaviors. Further studies in a variety of pain and nonpain settings are needed to determine the ORT's universal applicability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16336480     DOI: 10.1111/j.1526-4637.2005.00072.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  222 in total

Review 1.  Pragmatic Opioid Use in Painful Diabetic Neuropathy.

Authors:  Yatan Pal Singh Balhara; Shalini Singh; Sanjay Kalra
Journal:  Eur Endocrinol       Date:  2020-02-04

2.  Maladaptive opioid use behaviors and psychiatric illness: what should we do with what we know?

Authors:  C Patrick Carroll; Jennifer Haythornthwaite
Journal:  Curr Pain Headache Rep       Date:  2011-04

3.  Opioids and chronic pain.

Authors:  Lisa Bromley
Journal:  CMAJ       Date:  2012-01-10       Impact factor: 8.262

Review 4.  Substance abuse in cancer pain.

Authors:  Tatiana D Starr; Lauren J Rogak; Steven D Passik
Journal:  Curr Pain Headache Rep       Date:  2010-08

5.  Prescription use disorders in older adults.

Authors:  Raj K Kalapatapu; Maria A Sullivan
Journal:  Am J Addict       Date:  2010-09-21

6.  Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors.

Authors:  Kathleen W Saunders; Michael Von Korff; Cynthia I Campbell; Caleb J Banta-Green; Mark D Sullivan; Joseph O Merrill; Constance Weisner
Journal:  J Pain       Date:  2012-01-29       Impact factor: 5.820

7.  Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain.

Authors:  Jane M Liebschutz; Richard Saitz; Roger D Weiss; Tali Averbuch; Sonia Schwartz; Ellen C Meltzer; Elizabeth Claggett-Borne; Howard Cabral; Jeffrey H Samet
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

8.  Ondansetron Does Not Reduce Withdrawal in Patients With Physical Dependence on Chronic Opioid Therapy.

Authors:  Larry F Chu; John Sun; Anna Clemenson; Matthew J Erlendson; Tom Rico; Erika Cornell; Hannah Obasi; Zahra N Sayyid; Ellen M Encisco; Jeff Yu; Jamison G Gamble; Ian Carroll; J David Clark
Journal:  J Addict Med       Date:  2017 Sep/Oct       Impact factor: 3.702

9.  Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review.

Authors:  Emily Behar; Rita Bagnulo; Phillip O Coffin
Journal:  Prev Med       Date:  2018-06-15       Impact factor: 4.018

10.  Characteristics of Urban Inpatient Smokers With and Without Chronic Pain: Foundations for Targeted Cessation Programs.

Authors:  Gwendolyn R Cody; Binhuan Wang; Alissa R Link; Scott E Sherman
Journal:  Subst Use Misuse       Date:  2019-02-01       Impact factor: 2.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.